GlassScriptPhysician profile
Joseph Vassalotti
NPI 1689692311
$35,648.70
in general payments reported to CMS, 2019-2025
9 companies · $60.83 in 2025
The $60.83 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $29.10 · 2021: $2,846 · 2022: $12K · 2023: $9,500 · 2024: $11K · 2025: $60.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Travel and Lodging: $873 · Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,078.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Travel and Lodging | $873.24 |
| Food and Beverage | $655.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $16,500.00 | 2022-2023 | Kidneyintelx Blood Collection Convenience Kit |
| Novo Nordisk INC | $10,919.77 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $5,166.77 | 2022 | |
| Eli Lilly and Company | $2,750.00 | 2021 | |
| Genzyme Corporation | $126.72 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $95.51 | 2021 | |
| Aurinia Pharma U.S., INC. | $60.83 | 2025 | Lupkynis |
| Bayer Healthcare Pharmaceuticals INC. | $29.10 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Vassalotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.